- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00170261
ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope
June 30, 2025 updated by: Medtronic Cardiac Rhythm and Heart Failure
Early Loop-Recorder in Suspected Arrhythmogenic Syncope
This is a prospective, controlled, opened randomized study to evaluate the cost benefit of a primary implantation of a loop recorder versus the conventional diagnostic cascade for syncope most likely due to cardiac arrhythmia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10967
- Vivantes Klinikum Am Urban
-
Berlin, Germany, 13509
- Humbold Klinikum
-
Hamburg, Germany, 20251
- Universitatsklinikum Hamburg Eppendorf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Two or more episodes of syncope (most likely due to cardiac arrhythmia) of uncertain etiology within the last 12 months or more than one syncope and two presyncopes
Exclusion Criteria:
- Indication for the implantation of a pacemaker
- Indication for the implantation of an implantable cardioverter defibrillator
- Cardiac diseases which need intervention (KHK, aortic stenosis, mitral stenosis, left ventricular [LV] outflow stenosis, decompensated heart failure)
- Contraindication for a diagnostic procedure requested by the study protocol
- Enrollment in another study
- Circumstances or comorbidities which do not allow enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Cost of diagnostics per patient until final cardiac diagnosis has been made
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Cost of diagnostics until final diagnosis has been made
|
|
Rate of correct cardiac diagnoses
|
|
Comparison of time needed to make a diagnosis
|
|
Comparison of pre-syncopes and syncopes occuring in both groups after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: H.-C- Ehlers, MD, Vivantes Klinikum Am Urban
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2002
Primary Completion (Actual)
September 1, 2005
Study Completion (Actual)
September 1, 2006
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimated)
September 15, 2005
Study Record Updates
Last Update Posted (Actual)
July 3, 2025
Last Update Submitted That Met QC Criteria
June 30, 2025
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEN_G_CA_4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syncope
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
Tanvir HospitalEnrolling by invitationVasovagal Syncope (VVS)India
-
University of CalgaryRecruitingSyncope | Vasovagal Syncope (VVS)Canada
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
University of CalgaryRecruiting
-
Centre of Postgraduate Medical EducationTerminated
-
Dr. Bob SheldonVanderbilt UniversityActive, not recruitingVasovagal SyncopeUnited States, Canada, Poland
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
Clinical Trials on Use of an Implantable Loop Recorder
-
Luciano A. SposatoRecruiting
-
Leonardo Calò, MDNot yet recruiting
-
Northwell HealthAbbottRecruitingAtrial FibrillationUnited States
-
Odense University HospitalCompletedAtrial FibrillationDenmark, Sweden, Russian Federation
-
Fundación Instituto de Estudios de Ciencias de...Instituto de Salud Carlos III; Spanish Society of Cardiology; Sanidad de Castilla...Active, not recruitingMyocardial Infarction | Death, Sudden | Ventricular Tachycardia | Implantable Defibrillator User | Myocardial DysfunctionSpain
-
Canadian Institutes of Health Research (CIHR)Vanderbilt UniversityCompletedHeart Block | Syncope | Conduction Disorder of the HeartUnited Kingdom, Canada, United States, Malaysia, Japan
-
Barts & The London NHS TrustCompleted
-
University of PennsylvaniaMedtronicCompletedAtrial FibrillationUnited States
-
Seoul National University HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Bundang... and other collaboratorsActive, not recruitingAtrial Fibrillation, PersistentKorea, Republic of
-
Medical University of GrazMedtronicUnknownHypertension | Diabetes | Atrial Fibrillation | Chronic Heart Failure | Vascular DiseaseAustria